Biogen Inc.BIIBNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank29
3Y CAGR-9.0%
5Y CAGR-15.5%
Year-over-Year Change
Research and development spending
3Y CAGR
-9.0%/yr
vs -1.1%/yr prior
5Y CAGR
-15.5%/yr
Recent acceleration
Acceleration
-8.0pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.95B | -21.5% |
| 2024 | $2.49B | -7.9% |
| 2023 | $2.70B | +4.1% |
| 2022 | $2.60B | -23.6% |
| 2021 | $3.40B | -24.9% |
| 2020 | $4.53B | +63.5% |
| 2019 | $2.77B | +2.2% |
| 2018 | $2.71B | +14.2% |
| 2017 | $2.37B | +20.3% |
| 2016 | $1.97B | - |